Peripheral Drug Eluting Balloons Market Segmented By superficial femoral artery, popliteal lesions, infra-popliteal lesions, in-stent restenosis
Industry: Healthcare
Published Date: May-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 273
Report ID: PMRREP27211
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Drug Coating Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption/ Usage Analysis, by region
4.2. Regulatory Scenario
4.3. Technology Assessment
4.4. Value Chain Analysis
4.5. Recent Product Approvals and Launches
4.6. Porter’s Analysis
4.7. Product USP Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Peripheral Vascular Devices Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Growth in Healthcare Spending
5.2.2. Growth in Geriatric Population
5.2.3. Rising Number of Peripheral Surgeries
5.2.4. Technological Advancements
5.2.5. Regulatory Landscape
5.2.6. Cost of Procedures
5.2.7. Product Adoption Rate and Demand
5.2.8. Increase in Research and Development
5.2.9. Pharmaceutical Industry Consolidation Activities
5.2.10. Top Companies’ Historical Growth
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Drug Coating
6.1.2. By Indication
6.1.3. By Artery Type
6.1.4. By End User
6.1.5. By Region
6.2. 2022 Market Scenario
7. Global Market Demand in Volume (Units) Analysis 2012–2022 and Forecast, 2023–2033
7.1. Historical Market Volume (Units) Analysis, 2012–2022
7.2. Current and Future Market Volume (Units) (Units) Projections, 2023–2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Drug Coating
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value US$ Mn) Analysis 2012-2022 and Forecast, 2023-2033
9.1. Historical Market Value (US$ Mn) Analysis, 2012-2022
9.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
9.3. Revenue Opportunity Scenario
10. Global Market Analysis 2012-2022 and Forecast 2023-2033, By Drug Coating
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Drug Coating, 2012-2022
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, by Drug Coating, 2023-2033
10.3.1. Paclitaxel Drug Coating
10.3.2. Sirolimus drug Coating
10.3.3. Others
10.4. Market Attractiveness Analysis, by Drug Coating
11. Global Market Analysis 2012-2022 and Forecast 2023-2033, By Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2012-2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Indication, 2023-2033
11.3.1. Peripheral Arterial Disease
11.3.2. Peripheral Aneurysms
11.3.3. In-Stent Restenosis
11.3.4. Others
11.4. Market Attractiveness Analysis, by Indication
12. Global Market Analysis 2012-2022 and Forecast 2023-2033, By Artery Type
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis, By Artery Type, 2012-2022
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Artery Type, 2023-2033
12.3.1. Carotid Artery
12.3.2. Fem-Pop Artery
12.3.3. Iliac Artery
12.3.4. Infrapop Artery
12.4. Market Attractiveness Analysis, by Artery Type
13. Global Market Analysis 2012-2022 and Forecast 2023-2033, By End User
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis, By End User, 2012-2022
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2023-2033
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers/Outpatients
13.3.3. Cardiac Catheterization Labs
13.4. Market Attractiveness Analysis, by End User
14. Global Market Analysis 2012-2022 and Forecast 2023-2033, By Region
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Region, 2012-2022
14.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, By Region, 2023-2033
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. South Asia
14.3.5. East Asia
14.3.6. Oceania
14.3.7. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis, by Region
15. North America Market Analysis 2012-2022 and Forecast 2023-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022
15.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By Drug Coating
15.3.3. By Indication
15.3.4. By Artery Type
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug Coating
15.4.3. By Indication
15.4.4. By Artery Type
15.4.5. By End User
15.5. PESTLE Analysis
15.6. Market Trends
15.7. Key Market Participants – Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country Level Analysis & Forecast
15.9.1. U.S. Market Analysis
15.9.1.1. Introduction
15.9.1.2. Market Analysis and Forecast, by Market Taxonomy
15.9.1.2.1. By Drug Coating
15.9.1.2.2. By Indication
15.9.1.2.3. By Artery Type
15.9.1.2.4. By End User
15.9.2. Canada Market Analysis
15.9.2.1. Introduction
15.9.2.2. Market Analysis and Forecast, by Market Taxonomy
15.9.2.2.1. By Drug Coating
15.9.2.2.2. By Indication
15.9.2.2.3. By Artery Type
15.9.2.2.4. By End User
16. Latin America Market Analysis 2012-2022 and Forecast 2023-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022
16.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033
16.3.1. By Country
16.3.1.1. Mexico
16.3.1.2. Brazil
16.3.1.3. Argentina
16.3.1.4. Rest of Latin America
16.3.2. By Drug Coating
16.3.3. By Indication
16.3.4. By Artery Type
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Drug Coating
16.4.3. By Indication
16.4.4. By Artery Type
16.4.5. By End User
16.5. PESTLE Analysis
16.6. Market Trends
16.7. Key Market Participants – Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country Level Analysis & Forecast
16.9.1. Mexico Market Analysis
16.9.1.1. Introduction
16.9.1.2. Market Analysis and Forecast, by Market Taxonomy
16.9.1.2.1. By Drug Coating
16.9.1.2.2. By Indication
16.9.1.2.3. By Artery Type
16.9.1.2.4. By End User
16.9.2. Brazil Market Analysis
16.9.2.1. Introduction
16.9.2.2. Market Analysis and Forecast, by Market Taxonomy
16.9.2.2.1. By Drug Coating
16.9.2.2.2. By Indication
16.9.2.2.3. By Artery Type
16.9.2.2.4. By End User
16.9.3. Argentina Market Analysis
16.9.3.1. Introduction
16.9.3.2. Market Analysis and Forecast, by Market Taxonomy
16.9.3.2.1. By Drug Coating
16.9.3.2.2. By Indication
16.9.3.2.3. By Artery Type
16.9.3.2.4. By End User
17. Europe Market Analysis 2012-2022 and Forecast 2023-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022
17.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. U.K.
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Nordic Countries
17.3.1.9. Rest of Europe
17.3.2. By Drug Coating
17.3.3. By Indication
17.3.4. By Artery Type
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Drug Coating
17.4.3. By Indication
17.4.4. By Artery Type
17.4.5. By End User
17.5. PESTLE Analysis
17.6. Market Trends
17.7. Key Market Participants – Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
17.9. Country Level Analysis & Forecast
17.9.1. Germany Market Analysis
17.9.1.1. Introduction
17.9.1.2. Market Analysis and Forecast, by Market Taxonomy
17.9.1.2.1. By Drug Coating
17.9.1.2.2. By Indication
17.9.1.2.3. By Artery Type
17.9.1.2.4. By End User
17.9.2. Italy Market Analysis
17.9.2.1. Introduction
17.9.2.2. Market Analysis and Forecast, by Market Taxonomy
17.9.2.2.1. By Drug Coating
17.9.2.2.2. By Indication
17.9.2.2.3. By Artery Type
17.9.2.2.4. By End User
17.9.3. France Market Analysis
17.9.3.1. Introduction
17.9.3.2. Market Analysis and Forecast, by Market Taxonomy
17.9.3.2.1. By Drug Coating
17.9.3.2.2. By Indication
17.9.3.2.3. By Artery Type
17.9.3.2.4. By End User
17.9.4. U.K. Market Analysis
17.9.4.1. Introduction
17.9.4.2. Market Analysis and Forecast, by Market Taxonomy
17.9.4.2.1. By Drug Coating
17.9.4.2.2. By Indication
17.9.4.2.3. By Artery Type
17.9.4.2.4. By End User
17.9.5. Spain Market Analysis
17.9.5.1. Introduction
17.9.5.2. Market Analysis and Forecast, by Market Taxonomy
17.9.5.2.1. By Drug Coating
17.9.5.2.2. By Indication
17.9.5.2.3. By Artery Type
17.9.5.2.4. By End User
17.9.6. BENELUX Market Analysis
17.9.6.1. Introduction
17.9.6.2. Market Analysis and Forecast, by Market Taxonomy
17.9.6.2.1. By Drug Coating
17.9.6.2.2. By Indication
17.9.6.2.3. By Artery Type
17.9.6.2.4. By End User
17.9.7. Russia Market Analysis
17.9.7.1. Introduction
17.9.7.2. Market Analysis and Forecast, by Market Taxonomy
17.9.7.2.1. By Drug Coating
17.9.7.2.2. By Indication
17.9.7.2.3. By Artery Type
17.9.7.2.4. By End User
17.9.8. Nordic Countries Market Analysis
17.9.8.1. Introduction
17.9.8.2. Market Analysis and Forecast, by Market Taxonomy
17.9.8.2.1. By Drug Coating
17.9.8.2.2. By Indication
17.9.8.2.3. By Artery Type
17.9.8.2.4. By End User
18. East Asia Market Analysis 2012-2022 and Forecast 2023-2033
18.1. Introduction
18.2. Historical Market End User (US$ Mn) Analysis, by Market Taxonomy, 2012-2022
18.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Drug Coating
18.3.3. By Indication
18.3.4. By Artery Type
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Drug Coating
18.4.3. By Indication
18.4.4. By Artery Type
18.4.5. By End User
18.5. PESTLE Analysis
18.6. Market Trends
18.7. Key Market Participants – Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
18.9. Country Level Analysis & Forecast
18.9.1. China Market Analysis
18.9.1.1. Introduction
18.9.1.2. Market Analysis and Forecast, by Market Taxonomy
18.9.1.2.1. By Drug Coating
18.9.1.2.2. By Indication
18.9.1.2.3. By Artery Type
18.9.1.2.4. By End User
18.9.2. Japan Market Analysis
18.9.2.1. Introduction
18.9.2.2. Market Analysis and Forecast, by Market Taxonomy
18.9.2.2.1. By Drug Coating
18.9.2.2.2. By Indication
18.9.2.2.3. By Artery Type
18.9.2.2.4. By End User
18.9.3. South Korea Market Analysis
18.9.3.1. Introduction
18.9.3.2. Market Analysis and Forecast, by Market Taxonomy
18.9.3.2.1. By Drug Coating
18.9.3.2.2. By Indication
18.9.3.2.3. By Artery Type
18.9.3.2.4. By End User
19. South Asia Market Analysis 2012-2022 and Forecast 2023-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022
19.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Indonesia
19.3.1.3. Malaysia
19.3.1.4. Thailand
19.3.1.5. Rest of South Asia
19.3.2. By Drug Coating
19.3.3. By Indication
19.3.4. By Artery Type
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Drug Coating
19.4.3. By Indication
19.4.4. By Artery Type
19.4.5. By End User
19.5. PESTLE Analysis
19.6. Market Trends
19.7. Key Market Participants – Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
19.9. Country Level Analysis & Forecast
19.9.1. India Market Analysis
19.9.1.1. Introduction
19.9.1.2. Market Analysis and Forecast, by Market Taxonomy
19.9.1.2.1. By Drug Coating
19.9.1.2.2. By Indication
19.9.1.2.3. By Artery Type
19.9.1.2.4. By End User
19.9.2. Indonesia Market Analysis
19.9.2.1. Introduction
19.9.2.2. Market Analysis and Forecast, by Market Taxonomy
19.9.2.2.1. By Drug Coating
19.9.2.2.2. By Indication
19.9.2.2.3. By Artery Type
19.9.2.2.4. By End User
19.9.3. Malaysia Market Analysis
19.9.3.1. Introduction
19.9.3.2. Market Analysis and Forecast, by Market Taxonomy
19.9.3.2.1. By Drug Coating
19.9.3.2.2. By Indication
19.9.3.2.3. By Artery Type
19.9.3.2.4. By End User
19.9.4. Thailand Market Analysis
19.9.4.1. Introduction
19.9.4.2. Market Analysis and Forecast, by Market Taxonomy
19.9.4.2.1. By Drug Coating
19.9.4.2.2. By Indication
19.9.4.2.3. By Artery Type
19.9.4.2.4. By End User
20. Oceania Market 2012-2022 and Forecast 2022-2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022
20.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Drug Coating
20.3.3. By Indication
20.3.4. By Artery Type
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Drug Coating
20.4.3. By Indication
20.4.4. By Artery Type
20.4.5. By End User
20.5. PESTLE Analysis
20.6. Market Trends
20.7. Key Market Participants – Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
20.9. Country Level Analysis & Forecast
20.9.1. Australia Market Analysis
20.9.1.1. Introduction
20.9.1.2. Market Analysis and Forecast, by Market Taxonomy
20.9.1.2.1. By Drug Coating
20.9.1.2.2. By Indication
20.9.1.2.3. By Artery Type
20.9.1.2.4. By End User
20.9.2. New Zealand Market Analysis
20.9.2.1. Introduction
20.9.2.2. Market Analysis and Forecast, by Market Taxonomy
20.9.2.2.1. By Drug Coating
20.9.2.2.2. By Indication
20.9.2.2.3. By Artery Type
20.9.2.2.4. By End User
21. Middle East and Africa (MEA) Market Analysis 2012-2022 and Forecast 2023-2033
21.1. Introduction
21.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022
21.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Türkiye
21.3.1.3. Israel
21.3.1.4. South Africa
21.3.1.5. North Africa
21.3.1.6. Rest of Middle East and Africa
21.3.2. By Drug Coating
21.3.3. By Indication
21.3.4. By Artery Type
21.3.5. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Drug Coating
21.4.3. By Indication
21.4.4. By Artery Type
21.4.5. By End User
21.5. PESTLE Analysis
21.6. Market Trends
21.7. Key Market Participants – Intensity Mapping
21.8. Drivers and Restraints - Impact Analysis
21.9. Country Level Analysis & Forecast
21.9.1. GCC Countries Market Analysis
21.9.1.1. Introduction
21.9.1.2. Market Analysis and Forecast, by Market Taxonomy
21.9.1.2.1. By Drug Coating
21.9.1.2.2. By Indication
21.9.1.2.3. By Artery Type
21.9.1.2.4. By End User
21.9.2. Türkiye Market Analysis
21.9.2.1. Introduction
21.9.2.2. Market Analysis and Forecast, by Market Taxonomy
21.9.2.2.1. By Drug Coating
21.9.2.2.2. By Indication
21.9.2.2.3. By Artery Type
21.9.2.2.4. By End User
21.9.3. Israel Africa Market Analysis
21.9.3.1. Introduction
21.9.3.2. Market Analysis and Forecast, by Market Taxonomy
21.9.3.2.1. By Drug Coating
21.9.3.2.2. By Indication
21.9.3.2.3. By Artery Type
21.9.3.2.4. By End User
21.9.4. South Africa Market Analysis
21.9.4.1. Introduction
21.9.4.2. Market Analysis and Forecast, by Market Taxonomy
21.9.4.2.1. By Drug Coating
21.9.4.2.2. By Indication
21.9.4.2.3. By Artery Type
21.9.4.2.4. By End User
21.9.5. North Africa Market Analysis
21.9.5.1. Introduction
21.9.5.2. Market Analysis and Forecast, by Market Taxonomy
21.9.5.2.1. By Drug Coating
21.9.5.2.2. By Indication
21.9.5.2.3. By Artery Type
21.9.5.2.4. By End User
22. Market Structure Analysis
22.1. Market Analysis, by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
23. Competition Analysis
23.1. Competition Dashboard
23.2. Branding and Promotional Strategies, By Manufacturers
23.3. Key Development Analysis
23.4. Competition Deep Dive
23.4.1. Abbott Laboratories
23.4.1.1. Overview
23.4.1.2. Product Portfolio
23.4.1.3. Sales Footprint
23.4.1.4. Key Financials
23.4.1.5. SWOT Analysis
23.4.1.6. Key Developments
23.4.1.7. Strategy Overview
23.4.1.7.1. Marketing Strategy
23.4.1.7.2. Product Strategy
23.4.1.7.3. Channel Strategy
23.4.2. Boston Scientific Corporation
23.4.2.1. Overview
23.4.2.2. Product Portfolio
23.4.2.3. Sales Footprint
23.4.2.4. Key Financials
23.4.2.5. SWOT Analysis
23.4.2.6. Key Developments
23.4.2.7. Strategy Overview
23.4.2.7.1. Marketing Strategy
23.4.2.7.2. Product Strategy
23.4.2.7.3. Channel Strategy
23.4.3. Cook Medical Inc.
23.4.3.1. Overview
23.4.3.2. Product Portfolio
23.4.3.3. Sales Footprint
23.4.3.4. Key Financials
23.4.3.5. SWOT Analysis
23.4.3.6. Key Developments
23.4.3.7. Strategy Overview
23.4.3.7.1. Marketing Strategy
23.4.3.7.2. Product Strategy
23.4.3.7.3. Channel Strategy
23.4.4. MicroPort Scientific Corporation (Endovastec™)
23.4.4.1. Overview
23.4.4.2. Product Portfolio
23.4.4.3. Sales Footprint
23.4.4.4. Key Financials
23.4.4.5. SWOT Analysis
23.4.4.6. Key Developments
23.4.4.7. Strategy Overview
23.4.4.7.1. Marketing Strategy
23.4.4.7.2. Product Strategy
23.4.4.7.3. Channel Strategy
23.4.5. Medtronic Plc.
23.4.5.1. Overview
23.4.5.2. Product Portfolio
23.4.5.3. Sales Footprint
23.4.5.4. Key Financials
23.4.5.5. SWOT Analysis
23.4.5.6. Key Developments
23.4.5.7. Strategy Overview
23.4.5.7.1. Marketing Strategy
23.4.5.7.2. Product Strategy
23.4.5.7.3. Channel Strategy
23.4.6. Cardinal Health, Inc.
23.4.6.1. Overview
23.4.6.2. Product Portfolio
23.4.6.3. Sales Footprint
23.4.6.4. Key Financials
23.4.6.5. SWOT Analysis
23.4.6.6. Key Developments
23.4.6.7. Strategy Overview
23.4.6.7.1. Marketing Strategy
23.4.6.7.2. Product Strategy
23.4.6.7.3. Channel Strategy
23.4.7. B. Braun Melsungen AG
23.4.7.1. Overview
23.4.7.2. Product Portfolio
23.4.7.3. Sales Footprint
23.4.7.4. Key Financials
23.4.7.5. SWOT Analysis
23.4.7.6. Key Developments
23.4.7.7. Strategy Overview
23.4.7.7.1. Marketing Strategy
23.4.7.7.2. Product Strategy
23.4.7.7.3. Channel Strategy
23.4.8. BIOTRONIK SE & Co. KG
23.4.8.1. Overview
23.4.8.2. Product Portfolio
23.4.8.3. Sales Footprint
23.4.8.4. Key Financials
23.4.8.5. SWOT Analysis
23.4.8.6. Key Developments
23.4.8.7. Strategy Overview
23.4.8.7.1. Marketing Strategy
23.4.8.7.2. Product Strategy
23.4.8.7.3. Channel Strategy
23.4.9. Becton, Dickinson and Company
23.4.9.1. Overview
23.4.9.2. Product Portfolio
23.4.9.3. Sales Footprint
23.4.9.4. Key Financials
23.4.9.5. SWOT Analysis
23.4.9.6. Key Developments
23.4.9.7. Strategy Overview
23.4.9.7.1. Marketing Strategy
23.4.9.7.2. Product Strategy
23.4.9.7.3. Channel Strategy
23.4.10. W. L. Gore & Associates Inc.
23.4.10.1. Overview
23.4.10.2. Product Portfolio
23.4.10.3. Sales Footprint
23.4.10.4. Key Financials
23.4.10.5. SWOT Analysis
23.4.10.6. Key Developments
23.4.10.7. Strategy Overview
23.4.10.7.1. Marketing Strategy
23.4.10.7.2. Product Strategy
23.4.10.7.3. Channel Strategy
23.4.11. Getinge AB
23.4.11.1. Overview
23.4.11.2. Product Portfolio
23.4.11.3. Sales Footprint
23.4.11.4. Key Financials
23.4.11.5. SWOT Analysis
23.4.11.6. Key Developments
23.4.11.7. Strategy Overview
23.4.11.7.1. Marketing Strategy
23.4.11.7.2. Product Strategy
23.4.11.7.3. Channel Strategy
23.4.12. Terumo Corp
23.4.12.1. Overview
23.4.12.2. Product Portfolio
23.4.12.3. Sales Footprint
23.4.12.4. Key Financials
23.4.12.5. SWOT Analysis
23.4.12.6. Key Developments
23.4.12.7. Strategy Overview
23.4.12.7.1. Marketing Strategy
23.4.12.7.2. Product Strategy
23.4.12.7.3. Channel Strategy
23.4.13. Kyoto Medical Planning Co Ltd
23.4.13.1. Overview
23.4.13.2. Product Portfolio
23.4.13.3. Sales Footprint
23.4.13.4. Key Financials
23.4.13.5. SWOT Analysis
23.4.13.6. Key Developments
23.4.13.7. Strategy Overview
23.4.13.7.1. Marketing Strategy
23.4.13.7.2. Product Strategy
23.4.13.7.3. Channel Strategy
23.4.14. iVascular S.L.U
23.4.14.1. Overview
23.4.14.2. Product Portfolio
23.4.14.3. Sales Footprint
23.4.14.4. Key Financials
23.4.14.5. SWOT Analysis
23.4.14.6. Key Developments
23.4.14.7. Strategy Overview
23.4.14.7.1. Marketing Strategy
23.4.14.7.2. Product Strategy
23.4.14.7.3. Channel Strategy
23.4.15. AMG International GmbH
23.4.15.1. Overview
23.4.15.2. Product Portfolio
23.4.15.3. Sales Footprint
23.4.15.4. Key Financials
23.4.15.5. SWOT Analysis
23.4.15.6. Key Developments
23.4.15.7. Strategy Overview
23.4.15.7.1. Marketing Strategy
23.4.15.7.2. Product Strategy
23.4.15.7.3. Channel Strategy
23.4.16. ENDOCOR GmbH
23.4.16.1. Overview
23.4.16.2. Product Portfolio
23.4.16.3. Sales Footprint
23.4.16.4. Key Financials
23.4.16.5. SWOT Analysis
23.4.16.6. Key Developments
23.4.16.7. Strategy Overview
23.4.16.7.1. Marketing Strategy
23.4.16.7.2. Product Strategy
23.4.16.7.3. Channel Strategy
23.4.17. Meril Life Sciences Pvt. Ltd.
23.4.17.1. Overview
23.4.17.2. Product Portfolio
23.4.17.3. Sales Footprint
23.4.17.4. Key Financials
23.4.17.5. SWOT Analysis
23.4.17.6. Key Developments
23.4.17.7. Strategy Overview
23.4.17.7.1. Marketing Strategy
23.4.17.7.2. Product Strategy
23.4.17.7.3. Channel Strategy
23.4.18. Nano Therapeutics Pvt Ltd
23.4.18.1. Overview
23.4.18.2. Product Portfolio
23.4.18.3. Sales Footprint
23.4.18.4. Key Financials
23.4.18.5. SWOT Analysis
23.4.18.6. Key Developments
23.4.18.7. Strategy Overview
23.4.18.7.1. Marketing Strategy
23.4.18.7.2. Product Strategy
23.4.18.7.3. Channel Strategy
23.4.19. Koninklijke Philips N.V.
23.4.19.1. Overview
23.4.19.2. Product Portfolio
23.4.19.3. Sales Footprint
23.4.19.4. Key Financials
23.4.19.5. SWOT Analysis
23.4.19.6. Key Developments
23.4.19.7. Strategy Overview
23.4.19.7.1. Marketing Strategy
23.4.19.7.2. Product Strategy
23.4.19.7.3. Channel Strategy
23.4.20. REVA Medical
23.4.20.1. Overview
23.4.20.2. Product Portfolio
23.4.20.3. Sales Footprint
23.4.20.4. Key Financials
23.4.20.5. SWOT Analysis
23.4.20.6. Key Developments
23.4.20.7. Strategy Overview
23.4.20.7.1. Marketing Strategy
23.4.20.7.2. Product Strategy
23.4.20.7.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating
Table 02: Global Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating
Table 03: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication
Table 04: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type
Table 05: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User
Table 06: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Region
Table 07: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country
Table 08: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating
Table 09: North America Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating
Table 10: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication
Table 11: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type
Table 12: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User
Table 13: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country
Table 14: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating
Table 15: Latin America Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating
Table 16: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication
Table 17: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type
Table 18: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User
Table 19: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country
Table 20: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating
Table 21: Europe Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating
Table 22: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication
Table 23: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type
Table 24: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User
Table 25: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country
Table 26: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating
Table 27: East Asia Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating
Table 28: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication
Table 29: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type
Table 30: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User
Table 31: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country
Table 32: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating
Table 33: South Asia Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating
Table 34: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication
Table 35: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type
Table 36: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User
Table 37: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country
Table 38: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating
Table 39: Oceania Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating
Table 40: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication
Table 41: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type
Table 42: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User
Table 43: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country
Table 44: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating
Table 45: Middle East & Africa Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating
Table 46: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication
Table 47: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type
Table 48: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Global Peripheral Drug Eluting Balloons Market Volume (Units), 2012 – 2022
Figure 02: Global Peripheral Drug Eluting Balloons Market Volume (Units) & Y-o-Y Growth (%) Analysis,
Figure 03: Peripheral Drug Eluting Balloons, Pricing Analysis per unit (US$), in 2022
Figure 04: Peripheral Drug Eluting Balloons, Pricing Forecast per unit (US$), in 2033
Figure 05: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022
Figure 06: Global Peripheral Drug Eluting Balloons Market Forecast & Y-o-Y Growth, 2022–2033
Figure 07: Global Peripheral Drug Eluting Balloons Market Absolute $ Opportunity (US$ Mn) Analysis, 2022–2033
Figure 08: Global Peripheral Drug Eluting Balloons Market Value Share (%) Analysis 2022 and 2033, by Drug Coating
Figure 09: Global Peripheral Drug Eluting Balloons Market Y-o-Y Growth (%) Analysis 2023-2033, by Drug Coating
Figure 10: Global Peripheral Drug Eluting Balloons Market Attractiveness Analysis 2023–2033, by Drug Coating
Figure 11: Global Peripheral Drug Eluting Balloons Market Value Share (%) Analysis 2022 and 2033, by Indication
Figure 12: Global Peripheral Drug Eluting Balloons Market Y-o-Y Growth (%) Analysis 2023-2033, by Indication
Figure 13: Global Peripheral Drug Eluting Balloons Market Attractiveness Analysis 2023–2033, by Indication
Figure 14: Global Peripheral Drug Eluting Balloons Market Value Share (%) Analysis 2022 and 2033, by Artery Type
Figure 15: Global Peripheral Drug Eluting Balloons Market Y-o-Y Growth (%) Analysis 2023-2033, by Artery Type
Figure 16: Global Peripheral Drug Eluting Balloons Market Attractiveness Analysis 2023–2033, by Artery Type
Figure 17: Global Peripheral Drug Eluting Balloons Market Value Share (%) Analysis 2022 and 2033, by End User
Figure 18: Global Peripheral Drug Eluting Balloons Market Y-o-Y Growth (%) Analysis 2023-2033, by End User
Figure 19: Global Peripheral Drug Eluting Balloons Market Attractiveness Analysis 2023–2033, by End User
Figure 20: Global Peripheral Drug Eluting Balloons Market Value Share (%) Analysis 2022 and 2033, by Region
Figure 21: Global Peripheral Drug Eluting Balloons Market Y-o-Y Growth (%) Analysis 2023-2033, by Region
Figure 22: Global Peripheral Drug Eluting Balloons Market Attractiveness Analysis 2023–2033, by Region
Figure 23: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022
Figure 24: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033
Figure 25: North America Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)
Figure 26: North America Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)
Figure 27: North America Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)
Figure 28: North America Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)
Figure 29: North America Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)
Figure 30: North America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033
Figure 31: North America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033
Figure 32: North America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033
Figure 33: North America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033
Figure 34: North America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033
Figure 35:U.S. Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 36: Global Vs. U.S. Growth Comparison
Figure 37:U.S. Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 38:U.S. Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 39:U.S. Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 40:U.S. Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 41: Canada Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 42: Global Vs. Canada. Growth Comparison
Figure 43: Canada Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 44: Canada Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 45: Canada Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 46: Canada Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 47: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022
Figure 48: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033
Figure 49: Latin America Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)
Figure 50: Latin America Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)
Figure 51: Latin America Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)
Figure 52: Latin America Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)
Figure 53: Latin America Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)
Figure 54: Latin America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033
Figure 55: Latin America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033
Figure 56: Latin America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033
Figure 57: Latin America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033
Figure 58: Latin America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033
Figure 59: Mexico Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 60: Global Vs Mexico Growth Comparison
Figure 61: Mexico Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 62: Mexico Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 63: Mexico Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 64: Mexico Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 65: Brazil Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 66: Global Vs. Brazil. Growth Comparison
Figure 67: Brazil Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 68: Brazil Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 69: Brazil Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 70: Brazil Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 71: Argentina Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 72: Global Vs Argentina Growth Comparison
Figure 73: Argentina Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 74: Argentina Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 75: Argentina Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 76: Argentina Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 77: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022
Figure 78: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033
Figure 79: Europe Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)
Figure 80: Europe Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)
Figure 81: Europe Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)
Figure 82: Europe Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)
Figure 83: Europe Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)
Figure 84: Europe Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033
Figure 85: Europe Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033
Figure 86: Europe Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033
Figure 87: Europe Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033
Figure 88: Europe Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033
Figure 89: UK Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 90: Global Vs. UK Growth Comparison
Figure 91: UK Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 92: UK Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 93: UK Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 94: UK Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 95: Germany Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 96: Global Vs. Germany Growth Comparison
Figure 97: Germany Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 98: Germany Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 99: Germany Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 100: Germany Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 101: Italy Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 102: Global Vs. Italy Growth Comparison
Figure 103: Italy Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 104: Italy Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 105: Italy Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 106: Italy Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 107: France Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 108: Global Vs France Growth Comparison
Figure 109: France Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 110: France Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 111: France Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 112: France Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 113: Spain Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 114: Global Vs Spain Growth Comparison
Figure 115: Spain Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 116: Spain Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 117: Spain Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 118: Spain Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 119: Russia Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 120: Global Vs Russia Growth Comparison
Figure 121: Russia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 122: Russia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 123: Russia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 124: Russia Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 125: BENELUX Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 126: Global Vs BENELUX Growth Comparison
Figure 127: BENELUX Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 128: BENELUX Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 129: BENELUX Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 130: BENELUX Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 131: Nordics Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 132: Global Vs Nordics Growth Comparison
Figure 133: Nordics Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 134: Nordics Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 135: Nordics Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 136: Nordics Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 137: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022
Figure 138: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033
Figure 139: East Asia Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)
Figure 140: East Asia Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)
Figure 141: East Asia Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)
Figure 142: East Asia Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)
Figure 143: East Asia Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)
Figure 144: East Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033
Figure 145: East Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033
Figure 146: East Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033
Figure 147: East Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033
Figure 148: East Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033
Figure 149: China Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 150: Global Vs. China Growth Comparison
Figure 151: China Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 152: China Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 153: China Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 154: China Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 155: Japan Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 156: Global Vs. Japan Growth Comparison
Figure 157: Japan Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 158: Japan Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 159: Japan Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 160: Japan Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 161: South Korea Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 162: Global Vs South Korea Growth Comparison
Figure 163: South Korea Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 164: South Korea Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 165: South Korea Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 166: South Korea Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 167: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022
Figure 168: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033
Figure 169: South Asia Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)
Figure 170: South Asia Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)
Figure 171: South Asia Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)
Figure 172: South Asia Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)
Figure 173: South Asia Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)
Figure 174: South Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033
Figure 175: South Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033
Figure 176: South Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033
Figure 177: South Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033
Figure 178: South Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033
Figure 179: India Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 180: Global Vs. India Growth Comparison
Figure 181: India Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 182: India Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 183: India Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 184: India Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 185: Indonesia Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 186: Global Vs. Indonesia Growth Comparison
Figure 187: Indonesia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 188: Indonesia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 189: Indonesia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 190: Indonesia Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 191: Malaysia Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 192: Global Vs. Malaysia Growth Comparison
Figure 193: Malaysia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 194: Malaysia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 195: Malaysia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 196: Malaysia Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 197: Thailand Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 198: Global Vs. Thailand Growth Comparison
Figure 199: Thailand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 200: Thailand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 201: Thailand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 202: Thailand Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 203: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022
Figure 204: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033
Figure 205: Oceania Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)
Figure 206: Oceania Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)
Figure 207: Oceania Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)
Figure 208: Oceania Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)
Figure 209: Oceania Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)
Figure 210: Oceania Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033
Figure 211: Oceania Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033
Figure 212: Oceania Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033
Figure 213: Oceania Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033
Figure 214: Oceania Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033
Figure 215: Australia Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 216: Global Vs. Australia Growth Comparison
Figure 217: Australia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 218: Australia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 219: Australia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 220: Australia Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 221: New Zealand Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 222: Global Vs New Zealand Growth Comparison
Figure 223: New Zealand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 224: New Zealand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 225: New Zealand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 226: New Zealand Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 227: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022
Figure 228: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033
Figure 229: Middle East & Africa Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)
Figure 230: Middle East & Africa Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)
Figure 231: Middle East & Africa Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)
Figure 232: Middle East & Africa Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)
Figure 233: Middle East & Africa Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)
Figure 234: Middle East & Africa Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033
Figure 235: Middle East & Africa Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033
Figure 236: Middle East & Africa Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033
Figure 237: Middle East & Africa Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033
Figure 238: Middle East & Africa Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033
Figure 239: GCC Countries Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 240: Global Vs GCC Countries Growth Comparison
Figure 241: GCC Countries Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 242: GCC Countries Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 243: GCC Countries Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 244: GCC Countries Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 245: Türkiye Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 246: Global Vs. Türkiye Growth Comparison
Figure 247: Türkiye Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 248: Türkiye Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 249: Türkiye Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 250: Türkiye Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 251: Israel Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 252: Global Vs. Israel Growth Comparison
Figure 253: Israel Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 254: Israel Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 255: Israel Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 256: Israel Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 257: South Africa Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 258: Global Vs. South Africa Growth Comparison
Figure 259: South Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 260: South Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 261: South Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 262: South Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
Figure 263: North Africa Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022
Figure 264: Global Vs North Africa Growth Comparison
Figure 265: North Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033
Figure 266: North Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033
Figure 267: North Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033
Figure 268: North Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033
